Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
Bulletin of the World Health Organization
|
May 2, 2002
The microbial threat in fragile times: balancing known and unknown risks
David L Heymann
Bulletin of the World Health Organization
|
February 28, 2006
Control, elimination, eradication and re-emergence of infectious diseases: getting the message right
David L Heymann
BMJ (Clinical Research Ed.)
|
April 12, 2012
Challenges of drug resistance in the developing world
Ramanan Laxminarayan, David L Heymann
The Journal of Infectious Diseases
|
April 19, 2021
The Evolving Epidemiology of Human Monkeypox: Questions Still to Be Answered
David L Heymann, Karl Simpson
Lancet (London, England)
|
February 17, 2020
COVID-19: what is next for public health?
David L Heymann, Nahoko Shindo,
Infectious Diseases and Therapy
|
August 20, 2014
The problems with polio: toward eradication
Gemma Lien, David L Heymann
Future Virology
|
March 24, 2020
What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
Michael Edelstein, David L Heymann
Microbiology Spectrum
|
July 18, 2015
The Value of the One Health Approach: Shifting from Emergency Response to Prevention of Zoonotic Disease Threats at Their Source
David L Heymann, Matthew Dixon
Emerging Infectious Diseases
|
March 26, 2004
Global surveillance, national surveillance, and SARS
David L Heymann, Guénaël Rodier
Vaccine
|
April 11, 2012
Surveillance in eradication and elimination of infectious diseases: a progression through the years
David L Heymann, Larry Brilliant
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
Bulletin of the World Health Organization
|
May 2, 2002
The microbial threat in fragile times: balancing known and unknown risks
David L Heymann
Bulletin of the World Health Organization
|
February 28, 2006
Control, elimination, eradication and re-emergence of infectious diseases: getting the message right
David L Heymann
BMJ (Clinical Research Ed.)
|
April 12, 2012
Challenges of drug resistance in the developing world
Ramanan Laxminarayan, David L Heymann
The Journal of Infectious Diseases
|
April 19, 2021
The Evolving Epidemiology of Human Monkeypox: Questions Still to Be Answered
David L Heymann, Karl Simpson
Lancet (London, England)
|
February 17, 2020
COVID-19: what is next for public health?
David L Heymann, Nahoko Shindo,
Infectious Diseases and Therapy
|
August 20, 2014
The problems with polio: toward eradication
Gemma Lien, David L Heymann
Future Virology
|
March 24, 2020
What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
Michael Edelstein, David L Heymann
Microbiology Spectrum
|
July 18, 2015
The Value of the One Health Approach: Shifting from Emergency Response to Prevention of Zoonotic Disease Threats at Their Source
David L Heymann, Matthew Dixon
Emerging Infectious Diseases
|
March 26, 2004
Global surveillance, national surveillance, and SARS
David L Heymann, Guénaël Rodier
Vaccine
|
April 11, 2012
Surveillance in eradication and elimination of infectious diseases: a progression through the years
David L Heymann, Larry Brilliant
Page
of 13